Unknown

Dataset Information

0

Effect of an Immune-Boosting, Antioxidant and Anti-Inflammatory Food Supplement in Hospitalized COVID-19 Patients: A Prospective Randomized Pilot Study.


ABSTRACT:

Background

COVID-19 disease is a serious global health problem. Few treatments have been shown to reduce mortality and accelerate time to recovery. The aim of this study was to evaluate the potential effect of a food supplement (probiotics, prebiotics, vitamin D, zinc and selenium) in patients admitted with COVID-19.

Methods

A prospective randomized non-blinded clinical trial was conducted in a sample of 162 hospitalized patients diagnosed with COVID-19 recruited over eight months. All patients received standard treatment, but the intervention group (n = 67) was given one food supplement stick daily during their admission. After collecting the study variables, a statistical analysis was performed comparing the intervention and control groups and a multivariate analysis controlling for variables that could act as confounding factors.

Results

ROC curve analysis with an area under the curve (AUC) value of 0.840 (p < 0.001; 95%CI: 0.741-0.939) of the food supplement administration vs. recovery indicated good predictive ability. Moreover, the intervention group had a shorter duration of digestive symptoms compared with the control group: 2.6 ± 1.3 vs. 4.3 ± 2.2 days (p = 0.001); patients with non-severe disease on chest X-ray had shorter hospital stays: 8.1 ± 3.9 vs. 11.6 ± 7.4 days (p = 0.007).

Conclusions

In this trial, the administration of a food supplement (Gasteel Plus®) was shown to be a protective factor in the group of patients with severe COVID-19 and allowed early recovery from digestive symptoms and a shorter hospital stay in patients with a normal-mild-moderate chest X-ray at admission (ClinicalTrials.gov number, NCT04666116).

SUBMITTER: Reino-Gelardo S 

PROVIDER: S-EPMC10096722 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Effect of an Immune-Boosting, Antioxidant and Anti-Inflammatory Food Supplement in Hospitalized COVID-19 Patients: A Prospective Randomized Pilot Study.

Reino-Gelardo Sandra S   Palop-Cervera Marta M   Aparisi-Valero Nieves N   Espinosa-San Miguel Ignacio I   Lozano-Rodríguez Noelia N   Llop-Furquet Gonzalo G   Sanchis-Artero Laura L   Cortés-Castell Ernesto E   Rizo-Baeza Mercedes M   Cortés-Rizo Xavier X  

Nutrients 20230401 7


<h4>Background</h4>COVID-19 disease is a serious global health problem. Few treatments have been shown to reduce mortality and accelerate time to recovery. The aim of this study was to evaluate the potential effect of a food supplement (probiotics, prebiotics, vitamin D, zinc and selenium) in patients admitted with COVID-19.<h4>Methods</h4>A prospective randomized non-blinded clinical trial was conducted in a sample of 162 hospitalized patients diagnosed with COVID-19 recruited over eight months  ...[more]

Similar Datasets

| S-EPMC7575721 | biostudies-literature
| S-EPMC10064441 | biostudies-literature
| S-EPMC10670571 | biostudies-literature
| S-EPMC7278820 | biostudies-literature
| S-EPMC8277515 | biostudies-literature
| S-EPMC8750396 | biostudies-literature
| S-EPMC8874475 | biostudies-literature
| S-EPMC9212968 | biostudies-literature
| S-EPMC7532075 | biostudies-literature
| S-EPMC9144619 | biostudies-literature